Franklin Resources Inc Zentalis Pharmaceuticals, Inc. Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$37.41 - $62.25 $12.2 Million - $20.4 Million	-327,197 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$31.71 - $57.97 $4.82 Million - $8.82 Million	152,112 Added 86.88%	327,197 $17 Million
Q3 2020 Nov 12, 2020	BUY	$27.03 - $47.97 $946 - $1,678	35 Added 0.02%	175,085 $5.72 Million
Q2 2020 Aug 13, 2020	BUY	$23.2 - $54.8 $4.06 Million - $9.59 Million	175,050 New	175,050 $7.38 Million

143

68M

48.5K

89.6K

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $128M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.